PARATEK PHARMACEUTICALS
Paratek Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel tetracycline chemistry. Paratek's lead product candidate, omadacycline, is a new tetracycline-derived, broad-spectrum antibiotic being developed in both oral tablet and intravenous formulations for use as a first-line monotherapy antibiotic for ABSSSI, CABP, urinary tract infections (UTI) and other serious community-acquired bacte... rial infections, particularly when antibiotic resistance is of concern to prescribing physicians. Omadacycline has received Qualified Infectious Disease Product (QIDP) designation by the U.S. Food and Drug Administration for both the oral and intravenous formulations in all three of these infectious disease categories. Paratek has Special Protocol Assessment agreements with the FDA for the phase 3 trials planned in ABSSSI and CABP.
PARATEK PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care
Founded:
1996-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.paratekpharma.com
Total Employee:
101+
Status:
Active
Contact:
(617)807-6600
Email Addresses:
[email protected]
Total Funding:
133 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Domain Not Resolving Microsoft Exchange Online
Similar Organizations
Akari Therapeutics
Akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
resTORbio
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-10-30 | Transcept Pharmaceuticals | Transcept Pharmaceuticals acquired by Paratek Pharmaceuticals | N/A |
Investors List
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Post-IPO Equity - Paratek Pharmaceuticals
Omega Funds
Omega Funds investment in Post-IPO Debt - Paratek Pharmaceuticals
Aisling Capital
Aisling Capital investment in Post-IPO Debt - Paratek Pharmaceuticals
Abingworth
Abingworth investment in Post-IPO Debt - Paratek Pharmaceuticals
The Baupost Group
The Baupost Group investment in Post-IPO Debt - Paratek Pharmaceuticals
Aisling Capital
Aisling Capital investment in Post-IPO Equity - Paratek Pharmaceuticals
Pacific Growth Equities
Pacific Growth Equities investment in Post-IPO Equity - Paratek Pharmaceuticals
D. E. Shaw & Co.
D. E. Shaw & Co. investment in Post-IPO Equity - Paratek Pharmaceuticals
IBT Management Corporation
IBT Management Corporation investment in Post-IPO Equity - Paratek Pharmaceuticals
Official Site Inspections
http://www.paratekpharma.com Semrush global rank: 3.43 M Semrush visits lastest month: 4.5 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Paratek Pharmaceuticals"
Paratek Pharmaceuticals - LinkedIn
Positive outcomes. Positive patient stories. These are our priorities at Paratek Pharmaceuticals. As a commercial-stage biopharmaceutical company, we develop transformative solutions for patients ...See details»
Paratek Pharmaceuticals - Crunchbase Company Profile …
Contact Email [email protected] Phone Number 1 (617)807-6600 Paratek Pharmaceuticals is a biopharmaceutical company that focuses on the …See details»
Paratek Pharmaceuticals, Inc. - MassBio
Boston, MA 617-807-6600 Website @ParatekPharma LinkedIn Overview Paratek Pharmaceuticals, Inc., is a commercial-stage biopharmaceutical company focused on the …See details»
Paratek Pharmaceuticals, Inc. Company Profile | Boston, MA ...
Company Description: Paratek Pharmaceuticals is a commercial-stage biopharmaceutical company that develops and commercializes life-saving therapies for life-threatening diseases …See details»
Paratek - Overview, News & Similar companies | ZoomInfo.com
Paratek contact info: Phone number: (617) 807-6600 Website: www.paratekpharma.com What does Paratek do? Founded in 1996, Paratek is a clinical stage biopharmaceutical company …See details»
Paratek Pharmaceuticals
Feb 25, 2025 Paratek has been recognized with numerous awards, including being named as a Technology Pioneer at the World Economic Forum in 2018. The company has also been …See details»
Our Leadership - Paratek Pharma
I value being able to engage in meaningful collaboration across the Paratek organization, working with people who share a common goal of providing patients with access to a life-saving …See details»
Paratek Pharmaceuticals - Craft
Paratek Pharmaceuticals has 4 employees across 2 locations and $160.27 m in annual revenue in FY 2022. See insights on Paratek Pharmaceuticals including office locations, competitors, …See details»
Paratek Pharmaceuticals - PitchBook
Paratek Pharmaceuticals General Information Description. Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's medical research is based on …See details»
Paratek Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Www.paratekpharma.com. Holding Company | Public Company | 1996 | Massachusetts, United States | 250-500 | NASDAQ: PRTK | www.paratekpharma.com. Last update 08 May 2025. …See details»
Paratek Pharma - 2025 Company Profile - Tracxn
Apr 29, 2025 Paratek Pharma - Developer of therapeutics for antimicrobial resistant infections. Acquired by Gurnet Point Capital. Raised a total funding of $96.5M over 9 rounds from 25 …See details»
Working at Paratek Pharmaceuticals - Zippia
Www.paratekpharma.com. Organization Type. Public. CEO. Evan Loh M.d. Social Media. Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Boston, …See details»
Life - Paratek Pharma
Paratek is powered by the innovation and hard work of our employees. We acknowledge these successes through Paratek PROUD, our employee recognition and service award program. …See details»
Evan Loh, M.D. - President - Paratek Pharmaceuticals | LinkedIn
President, Chief Operating Officer and Chief Medical Officer at Paratek Pharmaceuticals · OFFICAL PARATEK CORPORATE LINKEDIN PROFILE. Evan Loh, M.D. has served as Chief …See details»
Paratek Pharma | News & Media
King of Prussia. 1000 First Avenue. Suite 200. King of Prussia, PA 19406See details»
About - Paratek Pharma
About Paratek. Positive outcomes. Positive patient stories. These are our priorities at Paratek Pharmaceuticals. We develop transformative solutions for patients with infectious diseases …See details»
Paratek Pharmaceuticals Completes Acquisition of Optinose,
2 days ago BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company focused on the development and...See details»
Paratek Pharmaceuticals, Inc. | VentureRadar
"Paratek Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases …See details»
Paratek Pharmaceuticals, Inc. Company Information - Drugs.com
Jun 11, 2018 Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided …See details»
Paratek Pharmaceuticals Completes Acquisition of Optinose, …
2 days ago BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company focused on the development and commercialization of …See details»